Ibuprofen Med Mentol Weifa

Ibuprofen, the active ingredient in Ibuprofen Med Mentol Weifa, is a nonsteroidal anti-inflammatory drug presented as a topical formulation for external use. It is used to relieve musculoskeletal pain, reduce inflammation, and alleviate minor aches and pains in adults.

GNH USA supplies Ibuprofen Med Mentol Weifa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory documentation to support global distribution. Our network ensures timely delivery and compliance with local import requirements.

Ibuprofen Med Mentol Weifa is an NSAID that acts locally to manage pain and inflammation in the musculoskeletal system. - Musculoskeletal pain: provides topical analgesia to reduce discomfort. - Inflammation: diminishes local swelling and erythema. - Minor aches and pains: alleviates everyday aches such as strains or sprains. - Joint stiffness: helps improve range of motion by reducing pain.

Topical ibuprofen may cause local skin reactions and, rarely, systemic adverse events.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Burning sensation: transient warmth or stinging after rubbing in. - Itching: occasional pruritus in the treated area. - Dryness: slight flaking or dryness of the skin.

Serious or Rare Side Effects: - Allergic dermatitis: widespread rash, swelling, or hives. - Angioedema: rapid swelling of lips, tongue, or face. - Stevens‑Johnson syndrome: severe blistering and mucosal involvement. - Systemic toxicity: signs of gastrointestinal bleeding or renal impairment if excessive absorption occurs.

When using Ibuprofen Med Mentol Weifa, observe the following precautions to ensure safe and effective therapy. - Contraindication: avoid use in individuals with known hypersensitivity to ibuprofen or other NSAIDs. - Application area: limit to intact skin; do not apply to open wounds or mucous membranes. - Duration: do not exceed the recommended period of continuous use, typically up to 7 days without medical advice. - Concomitant NSAIDs: refrain from using other topical or oral NSAIDs simultaneously to reduce risk of systemic effects. - Systemic absorption: monitor for signs of gastrointestinal upset or renal issues in patients with pre‑existing conditions. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Ibuprofen Med Mentol Weifa can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened chance of ulceration or bleeding. - ACE inhibitors or ARBs: may reduce renal function when combined. - Lithium: ibuprofen can raise lithium serum levels.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., beta‑blockers): possible reduction in blood pressure control. - Diuretics: risk of reduced renal perfusion. - Methotrexate: decreased clearance leading to toxicity. - SSRIs: modest increase in bleeding tendency. - Oral hypoglycemics: potential alteration of glucose control.